Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Antibodies (Basel, Switzerland)|April 23, 2024
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral InfectionKahlio Mader, Lynn B DustinBlood|October 19, 2007
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaEdgar D Charles, Rashidah M Green, Svetlana Marukian, et al.The Journal of Clinical Investigation|January 24, 2022
Searching for escape-resistant anti-SARS-CoV-2 neutralizing antibodiesRanjeet Singh Mahla, Lynn B DustinAnnual Review of Immunology|October 28, 2006
Flying under the radar: the immunobiology of hepatitis CLynn B Dustin, Charles M RiceFrontiers in Immunology|November 18, 2014
Interferon lambda: opportunities, risks, and uncertainties in the fight against HCVStephen M Laidlaw, Lynn B DustinThe Journal of Clinical Investigation|September 15, 2022
Lessons from a large-scale COVID-19 vaccine trialRanjeet Singh Mahla, Lynn B DustinBlood|April 30, 2005
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis CDavid Butera, Svetlana Marukian, Amy E Iwamaye, et al.Frontiers in Immunology|November 27, 2014
The Humoral Immune Response to HCV: Understanding is Key to Vaccine DevelopmentSiobhán B Cashman, Brian D Marsden, Lynn B DustinJournal of Leukocyte Biology|July 13, 2014
Immune control and failure in HCV infection--tipping the balanceLynn B Dustin, Siobhán B Cashman, Stephen M LaidlawFrontiers in Immunology|September 23, 2021
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune DiseaseEsther L Jones, Stephen M Laidlaw, Lynn B DustinPageof 6